Compare CLLS & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | SRFM |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.8M | 123.5M |
| IPO Year | 2014 | 2023 |
| Metric | CLLS | SRFM |
|---|---|---|
| Price | $0.97 | $0.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $4.45 | ★ $4.69 |
| AVG Volume (30 Days) | 55.6K | ★ 1.8M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $106,557,000.00 |
| Revenue This Year | N/A | $22.54 |
| Revenue Next Year | N/A | $26.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $0.40 |
| 52 Week High | $5.45 | $3.50 |
| Indicator | CLLS | SRFM |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 23.66 |
| Support Level | N/A | N/A |
| Resistance Level | $1.28 | $0.81 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 0.61 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.